POINT OF CARE DIAGNOSTICS FOR URINARY TRACT INFECTION
POINT OF CARE DIAGNOSTICS FOR URINARY TRACT INFECTION
批准号:
8394577
负责人:
KUMAR SUBRAMANIAN
金额:
$29.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-02 至 2014-12-31
关键词:
Accident and Emergency departmentAgeAntimicrobial susceptibilityBacteriaBacterial InfectionsBiological AssayBuffersCaringChildClinicalCoagulaseColony-forming unitsCommunicable DiseasesDetectionDevelopmentDevicesDiagnosisDiagnosticDiagnostic testsDiseaseDoctor of PhilosophyEnterococcusEscherichia coliExhibitsFemaleGenus staphylococcusGoalsGoldGrowthHourHypersensitivityIndividualInfectionKineticsKlebsiella pneumonia bacteriumLabelLaboratoriesLifeMarketingMedicineMicrofluidicsMolecularNucleic Acid ProbesOrganismPatientsPatternPeptide Nucleic AcidsProteus mirabilisPseudomonas aeruginosaPumpReproducibilityResourcesRibosomal RNARunningSamplingSepsisSexually Transmitted DiseasesSmall Business Innovation Research GrantSpecificitySpecimenSystemTechnologyTestingTimeTimeLineUnited StatesUniversitiesUrinary tract infectionUrineUrologic DiseasesWashingtonassay developmentbasebody systemclinically significantcost effectivedesignelectric impedanceinnovationmalemetermicroorganismnucleic acid detectionpathogenpoint-of-care diagnosticsprofessorsample collectionsensor
中文摘要
描述(由申请人提供):尿路感染(UTI)是一种非常常见的疾病,发生在所有年龄段的男性和女性以及儿童中。尿路感染是美国最常见的泌尿系统疾病,也是所有器官系统中第二常见的细菌感染。尿路感染(UTI)的定义是,无症状个体每毫升尿液中细菌菌落形成单位(CFU)超过105个,有症状个体每毫升尿液中细菌菌落形成单位(CFU)要低得多(~103 CFU/mL)。尿路感染诊断的“金标准”是微生物尿培养。然而,尿液培养系统的一个主要缺点是标本收集和病原体鉴定之间大约有2天的时间滞后。目前可用的快速诊断测试对尿路感染的敏感性和/r特异性较差。一种快速、灵敏、易于使用的基于POC的分子方法可以准确、可靠地检测和鉴定临床尿液标本中具有临床意义的细菌病原体浓度,这将是相当有益的。该SBIR项目的总体目标是开发一种成本效益高、灵敏度高、易于使用的设备,用于在护理点(POC)诊断尿路感染(UTI)。我们提出的技术将用于开发一种传感器阵列,专门用于与UTI最常见的微生物,包括大肠杆菌和凝固酶阴性葡萄球菌。在第二阶段,我们将扩大菜单,包括其他生物的检测,包括肺炎克雷伯菌、奇迹变形杆菌、肠球菌、铜绿假单胞菌。
英文摘要
DESCRIPTION (provided by applicant): Urinary tract infection (UTI) is an extremely common condition that occurs in both males and females of all ages and in children. UTI is the most common urological disease in the United States and the second most common bacterial infection of any organ system. Urinary tract infection (UTI) is defined by the presence of a growth of more than 105 colony forming units (CFU) of bacteria per mL of urine for asymptomatic individual and much lower for symptomatic individuals (~103 CFU/mL). The "gold standard" for UTI diagnosis is microbiological urine culture. However, a major drawback of urine culture systems is the time lag of approximately 2 days between specimen collection and pathogen identification. Currently available rapid diagnostic tests exhibit poor sensitivities and/r specificities for UTI. A rapid, sensitive, easy to use POC based molecular approach for accurate and reliable detection and identification of clinically significant concentrations of bacterial pathogens in clinical urine specimens would be of considerable benefit. The overall goal of this SBIR project is to develop a cost effective, sensitive, easy to use device for diagnosing Urinary Tract Infection (UTI) at the Point Of Care (POC). The application of our proposed technology will be directed towards the development of a sensor array specifically for the microorganisms most commonly associated with UTI including E. coli, and coagulase negative Staphylococcus. During PHASE II we will expand the menu to include for the detection of other organisms including Klebsiella pneumoniae, Proteus mirabilis, Enterococcus sp., Pseudomonas aeruginosa.
PUBLIC HEALTH RELEVANCE: Urinary tract infection (UTI) is an extremely common condition that occurs in both males and females of all ages and in children. Currently available rapid diagnostic tests exhibit poor sensitivities and/or specificities for UTI. A rapid, sensitive, easy o use POC based molecular approach for accurate and reliable detection and identification of clinically significant concentrations of bacterial pathogens in clinical urine specimens would be of considerable benefit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID POINT OF CARE DIAGNOSTICS FOR HCV
-
批准号:10497110
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Low cost, automated smartphone based assay for semen analysis
-
批准号:10028296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Multiplexed Point Of Care Nucleic Acid Assay for STI
-
批准号:9074908
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2016
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
IGF::OT::IGFTitle: Multiplexed Biosensor for Detecting Low Abundance Cancer-rel
-
批准号:8761949
-
项目类别:
-
资助金额:$99.98万
-
财政年份:2013
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
RAPID AND SENSITIVE IDENTIFICATION OF HIV ANTIGEN AT THE POINT OF USE
-
批准号:8603499
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2013
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Improved methodologies to measure novel alcohol biomarkers in whole blood
-
批准号:8183977
-
项目类别:
-
资助金额:$21.05万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
High throughput Point-of-Care assays for diabetes auto-antibody detection
-
批准号:8402736
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Multiplexed Biomarkers for staging Alzheimer???s Disease
-
批准号:8371247
-
项目类别:
-
资助金额:$17.08万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
High throughput Point-of-Care assays for diabetes auto-antibody detection
-
批准号:8546380
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MULTIPLEXED BIOSENSOR FOR DETECTING LOW ABUNDANCE CANCER
-
批准号:8356444
-
项目类别:
-
资助金额:$19.65万
-
财政年份:2011
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Home-Based Lithium Level Testing for Bipolar Patients
-
批准号:7922943
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2009
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Low-Cost, Onsite Biomarker Test Kits for Alcohol-Associated Disorders (Phoenix)
-
批准号:7947218
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2009
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
BIOMEDICAL (APPLIED/EXPLORATORY)
-
批准号:8039750
-
项目类别:
-
资助金额:$14.56万
-
财政年份:2009
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Real Time Monitoring of Environmental Exposure To Pesticides
-
批准号:7497426
-
项目类别:
-
资助金额:$29.72万
-
财政年份:2007
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Real Time Monitoring of Environmental Exposure To Pesticides
-
批准号:7362895
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2007
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Sternal Skin Conductance Monitoring
-
批准号:7012102
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2005
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Nanoliter Glucose Assay For Diabetics
-
批准号:6643891
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2003
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Continuous Alcohol Monitoring Device
-
批准号:6589580
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2002
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Continuous Alcohol Monitoring Device
-
批准号:7414517
-
项目类别:
-
资助金额:$41.7万
-
财政年份:2002
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Continuous Alcohol Monitoring Device
-
批准号:7234717
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2002
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: